Patents by Inventor Guy SALAMA

Guy SALAMA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210275642
    Abstract: The present invention includes methods, systems, uses, and means for the delivery of one or more anti-fibrotic agents into the pericardial space for the treatment and prevention of heart failure (HF).
    Type: Application
    Filed: December 17, 2020
    Publication date: September 9, 2021
    Applicant: University of Pittsburgh - Of the Commonwealth System of Higher Education
    Inventors: David Schwartzman, Sanjeev G. Shroff, Guy Salama, Charles McTiernan
  • Publication number: 20200087371
    Abstract: Disclosed herein are methods of using relaxin polypeptides and analogs, or nucleic acid molecules encoding such polypeptides to treat or inhibit atrial fibrillation.
    Type: Application
    Filed: July 11, 2019
    Publication date: March 19, 2020
    Inventors: David S. Schwartzman, Sanjeev G. Shroff, Guy Salama, Charles F. McTiernan
  • Publication number: 20180371046
    Abstract: The present invention relates to the use of relaxin for the treatment of lower urinary tract dysfunctions.
    Type: Application
    Filed: May 1, 2018
    Publication date: December 27, 2018
    Inventors: Anthony J. Kanai, Guy Salama, Irina Zabbarova, Youko Ikeda, Bethann Weber
  • Publication number: 20170342120
    Abstract: Disclosed herein are methods of using relaxin polypeptides and analogs, or nucleic acid molecules encoding such polypeptides to treat or inhibit atrial fibrillation.
    Type: Application
    Filed: April 7, 2017
    Publication date: November 30, 2017
    Inventors: David S. Schwartzman, Sanjeev G. Shroff, Guy Salama, Charles F. McTiernan
  • Publication number: 20170182128
    Abstract: The present invention includes methods, systems, uses, and means for the delivery of one or more anti-fibrotic agents into the pericardial space for the treatment and prevention of heart failure (HF).
    Type: Application
    Filed: March 10, 2017
    Publication date: June 29, 2017
    Applicant: University of Pittsburgh - Of the Commonwealth System of Higher Education
    Inventors: David Schwartzman, Sanjeev G. Shroff, Guy Salama, Charles McTiernan
  • Publication number: 20150232526
    Abstract: Disclosed herein are methods of using relaxin polypeptides and analogs, or nucleic acid molecules encoding such polypeptides to treat or inhibit atrial fibrillation.
    Type: Application
    Filed: October 10, 2013
    Publication date: August 20, 2015
    Applicant: University of Pittsburgh-Of the Commonwealth System of Higher Education
    Inventors: David S. SCHWARTZMAN, Sanjeev G. SHROFF, Guy SALAMA, Charles F. MCTIERNAN